(A) A hospice care program shall not admit any individual who does not meet the diagnosis and life expectancy requirements of a hospice patient defined in paragraph (J) of rule 3701-19-01 of the Administrative Code.
(B) A hospice care program shall admit patients, provide care and services, and discharge or transfer patients without discrimination on the basis of sex, age, race, creed, national origin, or handicap.
(C) A hospice care program shall require that the patient or the patient's authorized representative sign an informed consent form. This form shall include an acknowledgment by signature of the patient or patient's representative, that they have been:
(1) Given a full explanation of the palliative rather than curative nature of hospice care as it relates to the patient's terminal illness; and
(2) Informed that the patient may withdraw consent at any time.
(D) A hospice care program shall permit a hospice patient to withdraw consent for hospice care at any time.
(E) A hospice care program shall provide a patient or the patient's representative with information regarding the scope of services provided by the hospice care program, including any limitations of the hospice care program and charges for the services.
(F) A hospice care program shall distribute a copy of the written policy established under division (A) of section 3712.062 of the Revised Code and paragraph (D) of rule 3701-19-21 of the Administrative Code, to the patient and patient's family and discuss the procedures included in the policy with the patient and patient's family before providing hospice care and services;
(G) Prior to or within forty-eight hours after admission of each patient, a hospice care program shall obtain an oral statement from the patient's attending physician, if any, and the medical director of the hospice care program or the physician member of the interdisciplinary team, certifying that the patient is terminally ill. The program shall obtain written confirmation of the oral statement after admission. The written certification statement shall be signed by the patient's attending physician, if any, and the medical director of the hospice care program or the physician member of the interdisciplinary team.
(1) The program should obtain from each patient's attending physician, if any, designation of an alternate physician to contact for emergency care of the patient or review of the patient's plan of care when the attending physician is not available; and
(2) The hospice care program should obtain written confirmation of the oral statement certifying that the patient is terminally ill within a reasonable period of time after admission .
Five Year Review (FYR) Dates: 11/6/2019 and 01/13/2025
Promulgated Under: 119.03
Statutory Authority: 3712.03
Rule Amplifies: 3712.01, 3712.03 , 3712.06, 3712.062
Prior Effective Dates: 12/31/1990, 10/17/1999, 08/23/2009, 02/15/2015